Evidence mapPaperPMID 32020414Full record

Trial reportActa diabetologica2020

Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks.

J F Ortega, F Morales-Palomo, M Ramirez-Jimenez, A Moreno-Cabañas, R Mora-Rodríguez

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Acta diabetologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J F OrtegaExercise Physiology Laboratory, University of Castilla-La Mancha, 45071, Toledo, Spain.
F Morales-PalomoExercise Physiology Laboratory, University of Castilla-La Mancha, 45071, Toledo, Spain.
M Ramirez-JimenezExercise Physiology Laboratory, University of Castilla-La Mancha, 45071, Toledo, Spain.
A Moreno-CabañasExercise Physiology Laboratory, University of Castilla-La Mancha, 45071, Toledo, Spain.
R Mora-RodríguezExercise Physiology Laboratory, University of Castilla-La Mancha, 45071, Toledo, Spain. ricardo.mora@uclm.es.ORCID http://orcid.org/0000-0001-9252-4933
University of Castilla-La Mancha · ES

Funding

Ministerio de Economía, Industria y Competitividad, Gobierno de España DEP-2017-83244-R
6 · The paper itself

Abstract

purposeTo determine the separated and combined effects of metformin and exercise on insulin sensitivity and free-living glycemic control in overweight individuals with prediabetes/type 2 diabetes (T2DM).

methodsWe recruited 16 adults with BMI of 32.7 ± 4.3 kg m

resultsIFG

conclusionIntense aerobic exercise in patients with diabetes and prediabetes under metformin treatment reduces free-living 72-h blood hyperglycemic peaks. This may help to prevent the development of cardiovascular complications associated with diabetes.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringCombined Modality TherapyDiabetes Mellitus, Type 2ExerciseExercise TherapyExtracellular FluidFemaleGlucoseGlucose IntoleranceGlucose Tolerance TestHigh-Intensity Interval TrainingHumansHyperglycemiaInsulin ResistanceMaleBlood GlucoseGlucoseMetforminContinuous glucose monitoringExerciseHyperglycemiaInsulin sensitivityMetforminType 2 diabetes mellitus

Identifiers

PMID32020414
OpenAlexW3005435891

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.